The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of the Melanoma Tumor Burden Score (MTBS) in a real-world setting.
 
Michael Weichenthal
Honoraria - Bristol-Myers Squibb; Medac; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Millennium (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme
 
Gamze Senel
No Relationships to Disclose
 
Marcus Both
No Relationships to Disclose
 
Ilka Senkpiehl
No Relationships to Disclose
 
Dragana Lekic
No Relationships to Disclose
 
Katharina C. Kähler
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; MSD; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Roche/Genentech
Research Funding - MSD
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Roche/Genentech
 
Selma Ugurel
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Roche
Research Funding - Medac (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Ulrike M. Leiter
Honoraria - Bristol-Myers Squibb; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Peter Mohr
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Novartis; OncoSec; Philogen; Provectus; Regeneron; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar Therapeutics, Philogen, Provectus, Regeneron; Novartis; OncoSec; Roche
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; Merck Serono; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar Therapeutics, Philogen, Provectus, Regeneron; Novartis; OncoSec; Roche
 
Dirk Schadendorf
Honoraria - Agenus; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Grunenthal; Immunocore; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Philogen; Pierre Fabre; Regeneron; Roche/Genentech; Sysmex
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Grunenthal; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech; Sysmex
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech